{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T09:34:53Z","timestamp":1720517693725},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.transproceed.2009.06.096","type":"journal-article","created":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T08:51:21Z","timestamp":1249375881000},"page":"S13-S17","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S","title":["Optimizing Immunosuppression With Sirolimus in the First Year Posttransplantation: Experience in the United States"],"prefix":"10.1016","volume":"41","author":[{"given":"M.R.","family":"Weir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.K.","family":"Wali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2009.06.096_bib1","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/01.tp.0000219703.39149.85","article-title":"Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials","volume":"81","author":"Webster","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.06.096_bib2","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1097\/01.TP.0000093502.26208.42","article-title":"The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients","volume":"76","author":"Flechner","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.06.096_bib3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1600-6143.2005.01177.x","article-title":"Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus","volume":"6","author":"Larson","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2009.06.096_bib4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/TP.0b013e318195a421","article-title":"Calcineurin inhibitor sparing with mycophenolate in kidney transplantation: a systematic review and meta-analysis","volume":"87","author":"Moore","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.06.096_bib5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-6143.2004.00332.x","article-title":"Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2009.06.096_bib6","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.V1191735","article-title":"Explained and unexplained ischemic heart disease risk after renal transplantation","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2009.06.096_bib7","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/01.TP.0000062833.14843.4B","article-title":"Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration","volume":"75","author":"Meier-Kriesche","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.06.096_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-1755.2002.00424.x","article-title":"Post-transplant renal function in the first year predicts long-term kidney transplant survival","volume":"62","author":"Hariharan","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2009.06.096_bib9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantation in the United States, 1988 to 1996","volume":"342","author":"Hariharan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2009.06.096_bib10","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1097\/01.ASN.0000085019.95339.F0","article-title":"The stability of the glomerular filtration rate after renal transplantation is improving","volume":"14","author":"Gourishankar","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2009.06.096_bib11","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","article-title":"A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.06.096_bib12","series-title":"Medical Management of Kidney Transplantation","first-page":"389","article-title":"Approaching the renal transplant with deteriorating function: progressive loss of renal function is not inevitable","author":"Holloran","year":"2005"},{"key":"10.1016\/j.transproceed.2009.06.096_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients","volume":"60","author":"Sollinger","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.06.096_bib14","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1046\/j.1523-1755.2001.0590041567.x","article-title":"Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy","volume":"59","author":"Weir","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2009.06.096_bib15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000079390","article-title":"Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function","volume":"24","author":"Weir","year":"2004","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.transproceed.2009.06.096_bib16","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/j.1600-6143.2007.01825.x","article-title":"Early withdrawal of calcineurin inhibitors and rescue immunosuppression with sirolimus-based therapy in renal transplant recipients with moderate to severe renal dysfunction","volume":"7","author":"Wali","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2009.06.096_bib17","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/j.1600-6143.2004.00590.x","article-title":"Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction","volume":"4","author":"Diekmann","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2009.06.096_bib18","first-page":"10A","article-title":"Final 1-year outcomes of the Spare-the-Nephron (STN) trial: mycophenolate mofetil (MMF)-based regimen combined with sirolimus (SRL) to preserve renal function in renal transplantation","volume":"19","author":"Kalil","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2009.06.096_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial","volume":"87","author":"Schena","year":"2009","journal-title":"Transplantation"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134509008288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134509008288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T09:01:21Z","timestamp":1633770081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134509008288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0041134509008288"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2009.06.096","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}